Skip to main content

Advertisement

Advertisement

Singapore sends 100,000 doses of the Moderna Covid-19 vaccine to Brunei

SINGAPORE — Singapore has sent 100,000 doses of the Moderna Covid-19 vaccine to Brunei Darussalam as part of bilateral cooperation to tackle the pandemic, said the Ministry of Foreign Affairs (MFA) on Wednesday (Sept 29).

Vials of the Moderna Covid-19 vaccine are seen at Recipharm plant in Monts, France on April 22, 2021.

Vials of the Moderna Covid-19 vaccine are seen at Recipharm plant in Monts, France on April 22, 2021.

Follow TODAY on WhatsApp

SINGAPORE — Singapore has sent 100,000 doses of the Moderna Covid-19 vaccine to Brunei Darussalam as part of bilateral cooperation to tackle the pandemic, said the Ministry of Foreign Affairs (MFA) on Wednesday (Sept 29). 

Brunei will provide the same quantity of vaccines back to Singapore at a later date. 

"This mutually beneficial arrangement enables both countries to optimise our respective schedules for vaccinating our populations against Covid-19, and is part of our broader commitment to work together with our neighbours in confronting the pandemic," said MFA in a press statement.

In August, Singapore had similarly contributed 100,000 doses of the Moderna vaccine to Brunei to deepen cooperation between both countries.

Indonesia, Thailand and Malaysia are among other countries to which Singapore has contributed Covid-19 vaccines.

Last month, MFA also announced a "dose sharing arrangement" with Australia, which involves Singapore sending 500,000 doses of the Pfizer-BioNTech Covid-19 vaccine. Australia is to return the same amount in December. CNA

For more stories like this, visit cna.asia

Related topics

Moderna Covid-19 vaccine Brunei

Read more of the latest in

Advertisement

Advertisement

Stay in the know. Anytime. Anywhere.

Subscribe to get daily news updates, insights and must reads delivered straight to your inbox.

By clicking subscribe, I agree for my personal data to be used to send me TODAY newsletters, promotional offers and for research and analysis.